AutoML in Drug Discovery: Side-Effects Prediction Using AutoGluon Framework and Its Applications in Drug Discovery
Abstract
Recommendations
Drug Repurposing: Targeting mTOR Inhibitors for Anticancer Activity
CSBio '17: Proceedings of the 8th International Conference on Computational Systems-Biology and BioinformaticsIn the search of safer and more effective drugs while reducing costs and increasing productivity of novel drug discovery, scientists are changing their focus to an approach known as drug repurposing. This involves finding a new therapeutic effect of an ...
Artificial Intelligence for Drug Discovery
KDD '21: Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data MiningDrug discovery is a long and costly process, taking on average 10 years and 2.5 billion dollars to develop a new drug. Artificial intelligence has the potential to significantly accelerate the process of drug discovery by analyzing a large amount of ...
GPCR-drug interactions prediction using random forest with drug-association-matrix-based post-processing procedure
A new sequence-based predictor called TargetGDrug is designed and implemented for predicting GPCR-drug interactions. The evolutionary feature of GPCR sequence and the wavelet-based molecular fingerprint feature of drug are integrated to form the ...
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
Sponsors
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Check for updates
Author Tags
Qualifiers
- Abstract
Conference
Acceptance Rates
Upcoming Conference
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 53Total Downloads
- Downloads (Last 12 months)53
- Downloads (Last 6 weeks)5
Other Metrics
Citations
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign in